Novel targets for antibiotics

References

• COHEN ML: Epidemiology of drug resistance: implica-tions for a post-antimicrobial era. Science (1992) 257:1050–1055.
   PubMed Web of Science ®Google Scholar
• Discusses the rapid emergence of antibiotic resistance and the concerns for effects on future therapy.
   Google Scholar
• NEU HC: The crisis in antlbiotic resistance. Science (1992) 257:1064–1073.
   PubMed Web of Science ®Google Scholar
• Discusses mechanisms of antibiotic resistance and the current trends in multiple resistance emergence.
   Google Scholar
• FAOAGALI JL, THONG ML, GRANT D: Ten years' experi-ence with methicillin-resistant Staphylococcus aureus In a large Australian hospital. Journal of Hospital Infection (1992) 20:113–119.
   PubMed Web of Science ®Google Scholar
• SINGH M, CHAUDRY MA, YADAVA JN, SANYAL SC: The spectrum of antibiotic resistance in human and veteri-nary isolates of Escherichia colt collected from 1984-1986 in northern India. Journal of Antimicrobial Chemotherapy (1992) 29:159–168.
   PubMed Web of Science ®Google Scholar
• GIBBONS A: Exploring new strategies to fight drug-re- ('sistant microbes. Science (1992) 257:1036–1038.
   PubMed Web of Science ®Google Scholar
• Gives an editorial overview of the implications of antibiotic resis-tance.
   Google Scholar
• Anonymous. World market for anti-infectives. Marketletter1993 November 9, 1993.
   Google Scholar
• BARRETT JF, BERNSTEIN JI, LONGWILL HM, NGUYEN VN,OHEMENG KA: Use of poiymyxin B nonapeptide to facilitate penetration of quinolone and novel gyrase inhibitors across gram-negative cell walls and mem-branes. Annual Meeting of the American Society for Micro-biology. Atlanta, Georgia: American Society for Microbiology, (1993): A129.
   Google Scholar
• GLADUE RP, BRIGHT GM, ISAACSON RE, NEWBORG MF: In vitro and in vivo uptake of azithromydn (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrobial Agents and Chemotherapy (1989) 33:277–282.
   PubMed Web of Science ®Google Scholar
• Describes a novel method of drug delivery to sites of infections.
   Google Scholar
• ENGLISH AR, RETSEMA JA, GIRARD AE, LYNCH JE, BARTH WE: CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bac-teriological characterization. Antimicrobial Agents and Chemotherapy (1978) 14:414–419.
   PubMed Web of Science ®Google Scholar
• READING C, COLE M: Clavulanic acid: a beta-lactamase- inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrobial Agents and Chemotherapy (1977) 11:852-857. Describes the first important inhibitor of p-lactamase.
   Google Scholar
• YOSHIDA H, KOJIMA T, YAMAGISHI J-I, NAKAMURA S: Quinoione resistance mutations of the gyrA gene of Escherichia coll. Molecular and General Genetics (1988) 211:1–7.
   PubMedGoogle Scholar
• WOLFSON JS, HOOPER DC: Bacterial resistance to qui-nolones: mechanisms and clinical importance. Reviews in Infectious Diseases (1989) 11:8960–8968.
   Google Scholar
• CRUMPLIN GC: Mechanisms of resistance to the 4-qui-nolone antibacterial agents. Journal of Antimicrobial Che-motherapy (1990) 26(SF):131–144.
   Google Scholar
• HOLTJEJU, TOMASZ A: Purification of the pneumococcal N-acetylmuramyl-l-alanine amidase to biochemical ho-mogeneity. Journal of Biological Chemistry (1976) 251:4199–4207.
   PubMed Web of Science ®Google Scholar
• GELLERT M, MIZUUCHI K, O'DEA MIT, ITOH T, TOMIZAWA J: Nalidixic add resistance: a second genetic charac-teristic involved in DNA gyrase activity. Proceedings of the National Academy of Science, USA (1977) 74:4772–4776.
   PubMed Web of Science ®Google Scholar
• REECE RJ, MAXWELL A: DNA gyrase - structure and function. Critical Reviews in Biochemistry and Molecular Biology (1991) 26(3-4):335–375.
   PubMed Web of Science ®Google Scholar
• CIIUANG SE, DANIELS DL, BLATTNER FR: Global regula-tion of gene expression in Escherichia coil. J Bacteriol (1993) 175(7):2026–2036.
   PubMed Web of Science ®Google Scholar
• KOLB A, BUSBY S, BUC H, GARGES 5, ADHYA 5: Tran-scriptional regulation by cAMP and its receptor protein. Annu Rev Biochem (1993) 62:749–795.
   PubMed Web of Science ®Google Scholar
• WANG Q, CALVO JM: LRP, a global regulatory protein of Escberichia colt, binds co-operatively to multiple sites and activates transcription of ilvIH. J Mol Biol (1993) 229(2):306–318.
   PubMedGoogle Scholar
• BLYN LB, BRAATEN BA, LOW DA: Regulation of PAP pun phase variation by a mechanism involving differential Dam methylation states. EMBOJournal (1990) 9(12):4045–4054.
   PubMed Web of Science ®Google Scholar
• VANDERWOUDE MW, BRAA'TEN BA, LOW DA: Evidence for global regulatory control of pilus expression in Escherichia colt by Lrp and DNA methylation - Model building based on analysis of PAP. Mol Microbiol (1992) 6(173:2429–2435.
   PubMedGoogle Scholar
• STOCK JB, NINFA AL STOCK AM: Protein phosphoryla-tion and regulation of adaptive responses in bacteria. Microbiological Reviews (1989) 53:450–490.
   PubMedGoogle Scholar
• MAHAN MJ, SLAUCH JM, MEKALANOS JJ: Selection of bacterial virulence genes that are specifically inducedIn host tissues. Science (1993) 259:686–688.
   PubMed Web of Science ®Google Scholar
• Describes a novel technique to identify genes expressed exclusively in vivo.
   Google Scholar
• ISAACSON RE. Pilus adhesins. In: Bacterial Adhesion(1985). Savage DC, Fletcher M, (Eds.), Plenum Publishing Corporation, New York: pp. 307–336.
   Google Scholar